Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for prevention of recurrent spontaneous preterm labor
IRCT20191031045289N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin in preterm birth (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Incidence of preterm labor. Started Dec 2019; status: completed.
02
Drugs
aspirin
03
Conditions
preterm birth
Beyond the preview
Go deeper on IRCT20191031045289N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191031045289N1.